Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis
Top Cited Papers
- 31 March 2009
- journal article
- research article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 9 (3), 153-161
- https://doi.org/10.1016/s1473-3099(09)70041-6
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Multidrug- and Extensively Drug-Resistant Tuberculosis, GermanyEmerging Infectious Diseases, 2008
- Treatment Outcomes for HIV‐Uninfected Patients with Multidrug‐Resistant and Extensively Drug‐Resistant TuberculosisClinical Infectious Diseases, 2008
- Comprehensive Treatment of Extensively Drug-Resistant TuberculosisThe New England Journal of Medicine, 2008
- Has the DOTS Strategy Improved Case Finding or Treatment Success? An Empirical AssessmentPLOS ONE, 2008
- Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment FailuresPLOS ONE, 2007
- HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect StormThe Journal of Infectious Diseases, 2007
- Promoting adherence to treatment for tuberculosis: the importance of direct observationBulletin of the World Health Organization, 2007
- Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaThe Lancet, 2006
- Multidrug-resistant Tuberculosis Management in Resource-limited SettingsEmerging Infectious Diseases, 2006
- Cost-Effectiveness of Treating Multidrug-Resistant TuberculosisPLoS Medicine, 2006